[Successful cord blood transplantation for refractory gamma-delta hepatosplenic T-cell lymphoma developed during treatment of Crohn's disease]

Rinsho Ketsueki. 2024;65(1):41-46. doi: 10.11406/rinketsu.65.41.
[Article in Japanese]

Abstract

The patient was a 21-year-old man who had been diagnosed with Crohn's disease and received infliximab and azathioprine six years earlier. He was admitted with fever and fatigue. Peripheral blood examination showed LDH 2,473 U/l and thrombocytopenia, and contrast-enhanced computed tomography (CT) showed hepatosplenomegaly. Bone marrow biopsy and liver biopsy showed CD4+CD56+TCRγδ+CD8- atypical cells, leading to a diagnosis of hepatosplenic T-cell lymphoma (HSTCL). The patient was refractory to CHOP and DA-EPOCH, and therefore received cord blood transplantation with myeloablative conditioning. CT showed reduced in hepatosplenomegaly and peripheral blood examination showed LDH 165 U/l and plt 180,000/µl, so the patient was discharged on day117. HSTCL is a tumor of immature γδT cells with a Vδ1 mutation in the spleen, and immunodeficiency has been implicated in its pathogenesis. Patients with inflammatory bowel disease treated with azathioprine are known to have an increased risk of lymphoproliferative disease. In this case, use of immunosuppressive drugs for Crohn's disease may have caused malignant transformation of γδ cells in the intestinal epithelium. Although the patient was refractory to chemotherapy, he was able to achieve remission with early cord blood transplantation and long-term survival is expected.

Keywords: Cord blood transplantation; Crohn’s disease; Hepatosplenic T-cell lymphoma.

Publication types

  • Case Reports
  • English Abstract

MeSH terms

  • Adult
  • Azathioprine / adverse effects
  • Cord Blood Stem Cell Transplantation* / adverse effects
  • Crohn Disease* / chemically induced
  • Crohn Disease* / drug therapy
  • Humans
  • Immunosuppressive Agents / therapeutic use
  • Liver Neoplasms*
  • Lymphoma, T-Cell* / diagnosis
  • Lymphoma, T-Cell* / etiology
  • Lymphoma, T-Cell* / therapy
  • Male
  • Splenic Neoplasms* / etiology
  • Young Adult

Substances

  • Azathioprine
  • Immunosuppressive Agents